.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206910

« Back to Dashboard
NDA 206910 describes JADENU, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and two Paragraph IV challenges. Additional details are available on the JADENU profile page.

The generic ingredient in JADENU is deferasirox. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the deferasirox profile page.

Summary for NDA: 206910

Tradename:
JADENU
Applicant:
Novartis Pharms Corp
Ingredient:
deferasirox
Patents:3
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 206910

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
JADENU
deferasirox
TABLET;ORAL 206910 NDA Novartis Pharmaceuticals Corporation 0078-0654 0078-0654-15 30 TABLET, FILM COATED in 1 BOTTLE (0078-0654-15)
JADENU
deferasirox
TABLET;ORAL 206910 NDA Novartis Pharmaceuticals Corporation 0078-0655 0078-0655-15 30 TABLET, FILM COATED in 1 BOTTLE (0078-0655-15)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength90MG
Approval Date:Mar 30, 2015TE:RLD:No
Patent:6,465,504Patent Expiration:Apr 5, 2019Product Flag?YSubstance Flag?YDelist Request?
Patent:9,283,209Patent Expiration:Nov 21, 2034Product Flag?YSubstance Flag?YDelist Request?
Patent:6,596,750Patent Expiration:Jun 24, 2017Product Flag?Substance Flag?YDelist Request?
Patented Use:METHOD OF TREATING CHRONIC IRON OVERLOAD


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc